103 related articles for article (PubMed ID: 36901733)
21. Liquid versus tissue biopsy for detecting actionable alterations according to the ESMO Scale for Clinical Actionability of molecular Targets in patients with advanced cancer: a study from the French National Center for Precision Medicine (PRISM).
Bayle A; Peyraud F; Belcaid L; Brunet M; Aldea M; Clodion R; Dubos P; Vasseur D; Nicotra C; Geraud A; Sakkal M; Cerbone L; Blanc-Durand F; Mosele F; Martin Romano P; Ngo Camus M; Soubeyran I; Khalifa E; Alame M; Blouin L; Dinart D; Bellera C; Hollebecque A; Ponce S; Loriot Y; Besse B; Lacroix L; Rouleau E; Barlesi F; Andre F; Italiano A
Ann Oncol; 2022 Dec; 33(12):1328-1331. PubMed ID: 36122799
[No Abstract] [Full Text] [Related]
22. Predictors of germline status for hereditary melanoma: 5 years of multi-gene panel testing within the Italian Melanoma Intergroup.
Bruno W; Dalmasso B; Barile M; Andreotti V; Elefanti L; Colombino M; Vanni I; Allavena E; Barbero F; Passoni E; Merelli B; Pellegrini S; Morgese F; Danesi R; Calò V; Bazan V; D'Elia AV; Molica C; Gensini F; Sala E; Uliana V; Soma PF; Genuardi M; Ballestrero A; Spagnolo F; Tanda E; Queirolo P; Mandalà M; Stanganelli I; Palmieri G; Menin C; ; Pastorino L; Ghiorzo P
ESMO Open; 2022 Aug; 7(4):100525. PubMed ID: 35777164
[TBL] [Abstract][Full Text] [Related]
23. PrecisionFDA Truth Challenge V2: Calling variants from short and long reads in difficult-to-map regions.
Olson ND; Wagner J; McDaniel J; Stephens SH; Westreich ST; Prasanna AG; Johanson E; Boja E; Maier EJ; Serang O; Jáspez D; Lorenzo-Salazar JM; Muñoz-Barrera A; Rubio-Rodríguez LA; Flores C; Kyriakidis K; Malousi A; Shafin K; Pesout T; Jain M; Paten B; Chang PC; Kolesnikov A; Nattestad M; Baid G; Goel S; Yang H; Carroll A; Eveleigh R; Bourgey M; Bourque G; Li G; Ma C; Tang L; Du Y; Zhang S; Morata J; Tonda R; Parra G; Trotta JR; Brueffer C; Demirkaya-Budak S; Kabakci-Zorlu D; Turgut D; Kalay Ö; Budak G; Narcı K; Arslan E; Brown R; Johnson IJ; Dolgoborodov A; Semenyuk V; Jain A; Tetikol HS; Jain V; Ruehle M; Lajoie B; Roddey C; Catreux S; Mehio R; Ahsan MU; Liu Q; Wang K; Sahraeian SME; Fang LT; Mohiyuddin M; Hung C; Jain C; Feng H; Li Z; Chen L; Sedlazeck FJ; Zook JM
Cell Genom; 2022 May; 2(5):. PubMed ID: 35720974
[TBL] [Abstract][Full Text] [Related]
24. Genetic Layout of Melanoma Lesions Is Associated with BRAF/MEK-Targeted Therapy Resistance and Transcriptional Profiles.
Vergani E; Busico A; Dugo M; Devecchi A; Valeri B; Cossa M; Di Guardo L; De Cecco L; Feltrin E; Valle G; Deho P; Frigerio S; Lalli L; Gallino G; Del Vecchio M; Santinami M; Pruneri G; Tamborini E; Rivoltini L; Sensi M; Vallacchi V; Rodolfo M
J Invest Dermatol; 2022 Nov; 142(11):3030-3040.e5. PubMed ID: 35643181
[TBL] [Abstract][Full Text] [Related]
25. Promising Blood-Based Biomarkers for Melanoma: Recent Progress of Liquid Biopsy and Its Future Perspectives.
Kanemaru H; Mizukami Y; Kaneko A; Kajihara I; Fukushima S
Curr Treat Options Oncol; 2022 Apr; 23(4):562-577. PubMed ID: 35298769
[TBL] [Abstract][Full Text] [Related]
26. Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma.
Wolchok JD; Chiarion-Sileni V; Gonzalez R; Grob JJ; Rutkowski P; Lao CD; Cowey CL; Schadendorf D; Wagstaff J; Dummer R; Ferrucci PF; Smylie M; Butler MO; Hill A; Márquez-Rodas I; Haanen JBAG; Guidoboni M; Maio M; Schöffski P; Carlino MS; Lebbé C; McArthur G; Ascierto PA; Daniels GA; Long GV; Bas T; Ritchings C; Larkin J; Hodi FS
J Clin Oncol; 2022 Jan; 40(2):127-137. PubMed ID: 34818112
[TBL] [Abstract][Full Text] [Related]
27. TMB and Inflammatory Gene Expression Associated with Clinical Outcomes following Immunotherapy in Advanced Melanoma.
Hodi FS; Wolchok JD; Schadendorf D; Larkin J; Long GV; Qian X; Saci A; Young TC; Srinivasan S; Chang H; Tang H; Wind-Rotolo M; Rizzo JI; Jackson DG; Ascierto PA
Cancer Immunol Res; 2021 Oct; 9(10):1202-1213. PubMed ID: 34389558
[TBL] [Abstract][Full Text] [Related]
28. Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia.
Dalmasso B; Pastorino L; Nathan V; Shah NN; Palmer JM; Howlie M; Johansson PA; Freedman ND; Carter BD; Beane-Freeman L; Hicks B; Molven A; Helgadottir H; Sankar A; Tsao H; Stratigos AJ; Helsing P; Van Doorn R; Gruis NA; Visser M; Wadt KAW; Mann G; Holland EA; Nagore E; Potrony M; Puig S; Menin C; Peris K; Fargnoli MC; Calista D; Soufir N; Harland M; Bishop T; Kanetsky PA; Elder DE; Andreotti V; Vanni I; Bruno W; Höiom V; Tucker MA; Yang XR; Andresen PA; Adams DJ; Landi MT; Hayward NK; Goldstein AM; Ghiorzo P; ;
Genet Med; 2021 Nov; 23(11):2087-2095. PubMed ID: 34262154
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of BRAF and MEK Inhibition in Patients with BRAF-Mutant Advanced Melanoma and Germline CDKN2A Pathogenic Variants.
Spagnolo F; Dalmasso B; Tanda E; Potrony M; Puig S; van Doorn R; Kapiteijn E; Queirolo P; Helgadottir H; Ghiorzo P
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34069952
[TBL] [Abstract][Full Text] [Related]
30. The GNAQ T96S Mutation Affects Cell Signaling and Enhances the Oncogenic Properties of Hepatocellular Carcinoma.
Choi E; Park SJ; Lee G; Yoon SK; Lee M; Lee SK
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33807071
[TBL] [Abstract][Full Text] [Related]
31. ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancer.
Moreno T; Monterde B; González-Silva L; Betancor-Fernández I; Revilla C; Agraz-Doblas A; Freire J; Isidro P; Quevedo L; Blanco R; Montes-Moreno S; Cereceda L; Astudillo A; Casar B; Crespo P; Morales Torres C; Scaffidi P; Gómez-Román J; Salido E; Varela I
Oncogene; 2021 Apr; 40(16):2923-2935. PubMed ID: 33742126
[TBL] [Abstract][Full Text] [Related]
32. Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling.
Vergara IA; Mintoff CP; Sandhu S; McIntosh L; Young RJ; Wong SQ; Colebatch A; Cameron DL; Kwon JL; Wolfe R; Peng A; Ellul J; Dou X; Fedele C; Boyle S; Arnau GM; Raleigh J; Hatzimihalis A; Szeto P; Mooi J; Widmer DS; Cheng PF; Amann V; Dummer R; Hayward N; Wilmott J; Scolyer RA; Cho RJ; Bowtell D; Thorne H; Alsop K; Cordner S; Woodford N; Leditschke J; O'Brien P; Dawson SJ; McArthur GA; Mann GJ; Levesque MP; Papenfuss AT; Shackleton M
Nat Commun; 2021 Mar; 12(1):1434. PubMed ID: 33664264
[TBL] [Abstract][Full Text] [Related]
33. Circulating tumor DNA (ctDNA) detection is associated with shorter progression-free survival in advanced melanoma patients.
Marczynski GT; Laus AC; Dos Reis MB; Reis RM; Vazquez VL
Sci Rep; 2020 Oct; 10(1):18682. PubMed ID: 33122747
[TBL] [Abstract][Full Text] [Related]
34. Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patients.
Aoude LG; Bonazzi VF; Brosda S; Patel K; Koufariotis LT; Oey H; Nones K; Wood S; Pearson JV; Lonie JM; Arneil M; Atkinson V; Smithers BM; Waddell N; Barbour AP
Sci Rep; 2020 Oct; 10(1):17687. PubMed ID: 33077847
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of Acquired BRAF Inhibitor Resistance in Melanoma: A Systematic Review.
Proietti I; Skroza N; Bernardini N; Tolino E; Balduzzi V; Marchesiello A; Michelini S; Volpe S; Mambrin A; Mangino G; Romeo G; Maddalena P; Rees C; Potenza C
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 33003483
[TBL] [Abstract][Full Text] [Related]
36. Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications.
Vanni I; Tanda ET; Dalmasso B; Pastorino L; Andreotti V; Bruno W; Boutros A; Spagnolo F; Ghiorzo P
Front Mol Biosci; 2020; 7():172. PubMed ID: 32850962
[TBL] [Abstract][Full Text] [Related]
37. Current State of Target Treatment in BRAF Mutated Melanoma.
Tanda ET; Vanni I; Boutros A; Andreotti V; Bruno W; Ghiorzo P; Spagnolo F
Front Mol Biosci; 2020; 7():154. PubMed ID: 32760738
[TBL] [Abstract][Full Text] [Related]
38. Biological Factors behind Melanoma Response to Immune Checkpoint Inhibitors.
Olbryt M; Rajczykowski M; Widłak W
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517213
[TBL] [Abstract][Full Text] [Related]
39. Inactivation of
Gstalder C; Liu D; Miao D; Lutterbach B; DeVine AL; Lin C; Shettigar M; Pancholi P; Buchbinder EI; Carter SL; Manos MP; Rojas-Rudilla V; Brennick R; Gjini E; Chen PH; Lako A; Rodig S; Yoon CH; Freeman GJ; Barbie DA; Hodi FS; Miles W; Van Allen EM; Haq R
Cancer Discov; 2020 Sep; 10(9):1296-1311. PubMed ID: 32371478
[TBL] [Abstract][Full Text] [Related]
40. Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility.
Landi MT; Bishop DT; MacGregor S; Machiela MJ; Stratigos AJ; Ghiorzo P; Brossard M; Calista D; Choi J; Fargnoli MC; Zhang T; Rodolfo M; Trower AJ; Menin C; Martinez J; Hadjisavvas A; Song L; Stefanaki I; Scolyer R; Yang R; Goldstein AM; Potrony M; Kypreou KP; Pastorino L; Queirolo P; Pellegrini C; Cattaneo L; Zawistowski M; Gimenez-Xavier P; Rodriguez A; Elefanti L; Manoukian S; Rivoltini L; Smith BH; Loizidou MA; Del Regno L; Massi D; Mandala M; Khosrotehrani K; Akslen LA; Amos CI; Andresen PA; Avril MF; Azizi E; Soyer HP; Bataille V; Dalmasso B; Bowdler LM; Burdon KP; Chen WV; Codd V; Craig JE; Dębniak T; Falchi M; Fang S; Friedman E; Simi S; Galan P; Garcia-Casado Z; Gillanders EM; Gordon S; Green A; Gruis NA; Hansson J; Harland M; Harris J; Helsing P; Henders A; Hočevar M; Höiom V; Hunter D; Ingvar C; Kumar R; Lang J; Lathrop GM; Lee JE; Li X; Lubiński J; Mackie RM; Malt M; Malvehy J; McAloney K; Mohamdi H; Molven A; Moses EK; Neale RE; Novaković S; Nyholt DR; Olsson H; Orr N; Fritsche LG; Puig-Butille JA; Qureshi AA; Radford-Smith GL; Randerson-Moor J; Requena C; Rowe C; Samani NJ; Sanna M; Schadendorf D; Schulze HJ; Simms LA; Smithers M; Song F; Swerdlow AJ; van der Stoep N; Kukutsch NA; Visconti A; Wallace L; Ward SV; Wheeler L; Sturm RA; Hutchinson A; Jones K; Malasky M; Vogt A; Zhou W; Pooley KA; Elder DE; Han J; Hicks B; Hayward NK; Kanetsky PA; Brummett C; Montgomery GW; Olsen CM; Hayward C; Dunning AM; Martin NG; Evangelou E; Mann GJ; Long G; Pharoah PDP; Easton DF; Barrett JH; Cust AE; Abecasis G; Duffy DL; Whiteman DC; Gogas H; De Nicolo A; Tucker MA; Newton-Bishop JA; ; ; ; ; ; ; ; ; ; Peris K; Chanock SJ; Demenais F; Brown KM; Puig S; Nagore E; Shi J; Iles MM; Law MH
Nat Genet; 2020 May; 52(5):494-504. PubMed ID: 32341527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
